Delivery Order SPE2DB20D3103-SPE2DB24FN4Y0

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,614.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 13, 2024, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $1,639.62. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The contract, valued at $2,280.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 7, 2024. The contract was not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,872.19 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical valued at $999,999,999,...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,400.09. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,692.62 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 22, 2024 with an ultimate completion date of April 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $4,133.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $5,341.33 firm fixed-price delivery order has a period of performance through December 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $2,384.96 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 5, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,385.99 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply ADVAIR HFA 230-21 MCG INHALER 12GM to the agency. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FN4Y0
    Delivery Order

The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,144.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:40 AM